Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.25 - $7.4 $1.07 Million - $3.53 Million
-477,287 Reduced 73.08%
175,800 $1.2 Million
Q4 2023

Feb 13, 2024

BUY
$1.84 - $3.35 $437,200 - $795,990
237,609 Added 57.19%
653,087 $2.19 Million
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.77 $10,206 - $22,437
8,100 Added 1.99%
415,478 $1.04 Million
Q2 2023

Aug 11, 2023

BUY
$0.77 - $1.8 $144,435 - $337,640
187,578 Added 85.34%
407,378 $521,000
Q1 2023

May 12, 2023

SELL
$0.75 - $1.21 $73,633 - $118,795
-98,178 Reduced 30.88%
219,800 $178,000
Q4 2022

Feb 13, 2023

SELL
$0.54 - $1.12 $8,807 - $18,268
-16,311 Reduced 4.88%
317,978 $242,000
Q3 2022

Nov 14, 2022

BUY
$0.86 - $1.55 $60,295 - $108,672
70,111 Added 26.54%
334,289 $311,000
Q2 2022

Aug 12, 2022

SELL
$0.76 - $2.64 $13,696 - $47,578
-18,022 Reduced 6.39%
264,178 $250,000
Q1 2022

May 13, 2022

BUY
$1.48 - $6.22 $391,608 - $1.65 Million
264,600 Added 1503.41%
282,200 $595,000
Q4 2021

Feb 11, 2022

BUY
$8.77 - $18.29 $154,352 - $321,904
17,600 New
17,600 $158,000
Q2 2020

Aug 13, 2020

SELL
$29.41 - $51.23 $573,083 - $998,267
-19,486 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$19.54 - $55.47 $380,756 - $1.08 Million
19,486 New
19,486 $637,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.